Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 793, Issue 2, 2003, Pages 377-388

  Springer, Dietmar ^a   Fritschi, Giselher ^b   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Hessisches Landeskriminalamt   (Germany)

Author keywords

3 ,4 Methylenedioxy pyrrolidinopropiophenone; Designer drug; Metabolism; Toxicological detection

Indexed keywords

GAS CHROMATOGRAPHY; MASS SPECTROMETRY; TOXICITY;

SOLID-PHASE EXTRACTION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

3',4' METHYLENEDIOXY ALPHA PYRROLIDINOPROPIOPHENONE; CATECHOL; DESIGNER DRUG; DIKETONE; HYDROXYL GROUP; LACTAM; PROPIOPHENONE DERIVATIVE; PYRROLIDINE DERIVATIVE; TRIMETHYLSILYL DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CONTROLLED STUDY; DEAMINATION; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HYDROGENATION; HYDROXYLATION; MALE; MASS SPECTROMETRY; METABOLISM; METABOLITE; METHYLATION; MOLECULAR LIBRARY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SCREENING TEST; SOLID PHASE EXTRACTION; SPECTRUM; TOXICOLOGY; URINALYSIS;

EID: 0142122818     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00350-7     Document Type: Article

References (36)

1. Roesner P., Junge T., Fritschi G., Klein B., Thielert K., Kozlowski M. Toxichem. Krimtech. 66:1999;81.
2. Springer D., Peters F.T., Fritschi G., Maurer H.H. Pragst F., Aderjan R. Proceedings of the 12th GTFCh Symposium, Mosbach: 2001;156 Helm, Heppenheim.
3. Springer D., Peters F.T., Fritschi G., Maurer H.H. Balikova M., Navakova E. Proceedings of the 39th International TIAFT Meeting, Prague, 2001: 2002;122 Charles University, Prague.
4. Springer D., Peters F.T., Fritschi G., Maurer H.H. J. Chromatogr. B. 773:2002;25.
5. Martinez M., Mercado O., Santamaria A., Galvan S., Vazquez M., Bucio V., Hall C., Hernandez R., Hurtazo A., Pego E., Rodriguez F., Salvatierra R., Sosa A., Rios C. Proc. West. Pharmacol. Soc. 41:1998;125.
6. Glennon R.A., Yousif M., Naiman N., Kalix P. Pharmacol. Biochem. Behav. 26:1987;547.
7. Kalix P., Glennon R.A. Biochem. Pharmacol. 35:1986;3015.
8. Bryant S.G., Guernsey B.G., Ingrim N.B. Clin. Pharm. 2:1983;525.
9. D. Springer, F.T. Peters, G. Fritschi, H.H. Maurer, J. Chromatogr. B, in press.
10. Maurer H.H., Bickeboeller-Friedrich J. J. Anal. Toxicol. 24:2000;340.
11. McKay A.F., Ott W.L., Taylor G.W., Buchanan M.N., Crooker J.F. Can. J. Res. 28:(Sec. B):1950;683.
12. Kraemer T., Weber A.A., Maurer H.H. Pragst F. Proceedings of the 10th GTFCh Symposium, Mosbach: 1997;200 Helm, Heppenheim.
13. Maurer H.H. Pfleger K., Maurer H.H., Weber A. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 4. 2000;3 Wiley-VCH, Weinheim.
14. Maurer H.H., Bickeboeller-Friedrich J., Kraemer T., Peters F.T. Toxicol. Lett. 112:2000;133.
15. Maurer H.H. Spectrosc. Eur. 6:1994;21.
16. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Agilent Technologies, Palo Alto, CA, 2003, in preparation.
17. Staack R.F., Fritschi G., Maurer H.H. J. Chromatogr. B. 773:2002;35.
18. Bickeboeller-Friedrich J., Maurer H.H. Ther. Drug Monit. 23:2001;61.
19. Maurer H.H. Comb. Chem. High Throughput Screen. 3:2000;461.
20. Pokrajac M., Miljkovic B., Misailovic B. Rapid Commun. Mass Spectrom. 5:1991;59.
21. Brenneisen R., Geisshusler S. Pharm. Acta Helv. 60:1985;290.
22. Kraemer T., Bickeboeller-Friedrich J., Maurer H.H. Drug Metab. Dispos. 28:2000;339.
23. Pfleger K., Maurer H.H., Weber A. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 4. 2000;Wiley-VCH, Weinheim.
24. McLafferty F.W., Turecek F. Interpretation of Mass Spectra. 1993;University Science Books, Mill Valley, CA.
25. Smith R.M., Busch K.L. Understanding Mass Spectra - A Basic Approach. 1999;Wiley, New York.
26. Pfleger K., Maurer H.H., Weber A. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites. 1992;VCH, Weinheim.
27. Maurer H.H., Bickeboeller-Friedrich J. Ther. Drug Monit. 19:1997;583.
28. Kraemer T., Maurer H.H. Ther. Drug Monit. 24:2002;277.
29. Beckett A.H., Stanojcic M. J. Pharm. Pharmacol. 39:1987;409.
30. Markantonis S.L., Kyroudis A., Beckett A.H. Biochem. Pharmacol. 35:1986;529.
31. Schwetlick K. Organikum. 2001;Wiley-VCH, Weinheim.
32. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 5, Wiley-VCH, Weinheim, 2003, in preparation.
33. Kovats E. Helv. Chim. Acta. 41:1958;1915.
34. de-Zeeuw R.A., Franke J.P., Maurer H.H., Pfleger K. Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG Commission for Clinical Toxicological Analysis, Special Issue of the TIAFT bulletin). 1992;VCH, Weinheim, New York, Basle.
35. J. Clin. Chem. Clin. Biochem. 20:1982;699.
36. D. Springer, G. Fritschi, H.H. Maurer, J. Chromatogr. B, submitted for publication.